Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of tapinarof in adults with palmoplantar keratoderma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Keratoderma

Drugs mentioned

• Tapinarof (tapinarof)

Snippet

Sponsor: Indiana University | Conditions: Palmoplantar Keratoderma | Phase 2 | Status: RECRUITING